The medico-legal significance of pharmacokinetic interactions with ethanol

被引:3
|
作者
Langford, N. J. [1 ]
Ferner, R. E. [2 ]
机构
[1] Leicester Royal Infirm, Leicester LE1 5WW, Leics, England
[2] Univ Birmingham, Dept Clin Pharmacol, Birmingham B15 2TT, W Midlands, England
关键词
LIVER ALCOHOL DEHYDROGENASE; 1ST PASS METABOLISM; BLOOD-ALCOHOL; RANITIDINE INCREASES; CHLORAL HYDRATE; HUMANS; PERFORMANCE; ABSORPTION; INTOXICATION; ELIMINATION;
D O I
10.1258/msl.2012.012069
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
In the UK, the maximal permitted ethanol concentration for driving is 80 mg ethanol/100 mL blood, 35 g ethanol/100 mL breath or 107 mg ethanol/100 mL urine. Drivers exceeding the prescribed limit face severe penalties, which they are often anxious to avoid, either by acquittal or by putting forward special reasons' why they should not be disqualified from driving. One frequently explored defence is that the accused was taking prescribed medication. Defence solicitors often ask the question whether the prescribed medication could have caused significantly altered blood ethanol concentrations. This paper reviews the impact of various medications and how they can influence the blood ethanol concentration. Although many drugs can interact with ethanol at a pharmacodynamic level, causing increased impairment, relatively few drugs interact with ethanol pharmacokinetically leading to significantly altered blood ethanol concentrations.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions
    Ward, K. W.
    Coon, D. J.
    Magiera, D.
    Bhadresa, S.
    Struharik, M.
    Lawrence, M. S.
    XENOBIOTICA, 2009, 39 (03) : 266 - 272
  • [22] Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin
    Tvrdy, Vaclav
    Pourova, Jana
    Jirkovsky, Eduard
    Kren, Vladimir
    Valentova, Katerina
    Mladenka, Premysl
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (04) : 2195 - 2246
  • [23] In vivo pharmacodynamic and pharmacokinetic interactions of Hibiscus sabdariffa calyces extracts with simvastatin
    Showande, S. J.
    Adegbolagun, O. M.
    Igbinoba, S. I.
    Fakeye, T. O.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (06) : 695 - 703
  • [24] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Kasichayanula, Sreeneeranj
    Chang, Ming
    Liu, Xiaoni
    Shyu, Wen-Chyi
    Griffen, Steven C.
    LaCreta, Frank P.
    Boulton, David W.
    ADVANCES IN THERAPY, 2012, 29 (02) : 163 - 177
  • [25] Oral Antibiotic Drug Interactions of Clinical Significance to Dermatologists
    Del Rosso, James Q.
    DERMATOLOGIC CLINICS, 2009, 27 (01) : 91 - +
  • [26] Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling
    Li, Size
    Yu, Yiqun
    Jin, Zhiping
    Dai, Yu
    Lin, Haishu
    Jiao, Zheng
    Ma, Guo
    Cai, Weimin
    Han, Bing
    Xiang, Xiaoqiang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 119
  • [27] Selected pharmacokinetic drug interactions during treatment of epilepsy. Part II
    Jastrzebski, Karol
    Kacperska, Magdalena Justyna
    Kozera-Kepiniak, Alicja
    Klimek, Andrzej
    AKTUALNOSCI NEUROLOGICZNE, 2013, 13 (01): : 50 - 55
  • [28] Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramine
    Cruz, Hans G.
    Hay, Justin L.
    Hoever, Petra
    Alessi, Federica
    Beek, Erik T. te
    van Gerven, Joop M. A.
    Dingemanse, Jasper
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (08) : 1257 - 1268
  • [29] The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group
    Koziolek, Mirko
    Alcaro, Stefano
    Augustijns, Patrick
    Basit, Abdul W.
    Grimm, Michael
    Hens, Bart
    Hoad, Caroline L.
    Jedamzik, Philipp
    Madla, Christine M.
    Maliepaard, Marc
    Marciani, Luca
    Maruca, Annalisa
    Parrott, Neil
    Pavek, Petr
    Porter, Christopher J. H.
    Reppas, Christos
    van Riet-Nales, Diana
    Rubbens, Jari
    Statelova, Marina
    Trevaskis, Natalie L.
    Valentova, Katerina
    Vertzoni, Maria
    Cepo, Dubravka Vitali
    Corsetti, Maura
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 134 : 31 - 59
  • [30] Publication bias on clinical studies of pharmacokinetic interactions between felodipine and grapefruit juice
    Uesawa, Y.
    Takeuchi, T.
    Mohri, K.
    PHARMAZIE, 2010, 65 (05): : 375 - 378